Quarterly report pursuant to Section 13 or 15(d)

Common Stock and Employee Equity Plans (Tables)

v3.23.1
Common Stock and Employee Equity Plans (Tables) - USD ($)
shares in Thousands, $ in Millions
 3 Months Ended
Apr. 01, 2023
Mar. 26, 2022
Equity [Abstract]    
Schedule of Common Shares Outstanding
Common Stock
Shares of common stock outstanding were as follows:
Three Months Ended
April 1,
2023		 March 26,
2022
(In millions)
Balance, beginning of period 1,612  1,207 
Common stock issued in the acquisition of Xilinx —  429 
Common stock issued under employee equity plans 1  1 
Common stock repurchases for tax withholding on equity awards (1) (1)
Repurchases of common stock (3) (16)
Balance, end of period 1,609  1,620 
 
Share-based Payment Arrangement, Expensed and Capitalized, Amount
Stock-based Compensation
Stock-based compensation expense recorded in the Condensed Consolidated Statements of Operations was as follows: 
Three Months Ended
April 1,
2023		 March 26,
2022
(In millions)
Cost of sales $ 8  $ 4 
Research and development 214  113 
Marketing, general and administrative 87  82 
Total $ 309  $ 199 
 
Stock Repurchased During Period, Shares 3,000  
Payments for Repurchase of Common Stock $ 241 $ 1,914